triamterene has been researched along with Abdominal Migraine in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe the course of Meniere's disease with noninvasive treatment during the first few years after initial diagnosis." | 1.48 | Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine. ( Christov, F; Gluth, MB; Sbeih, F, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sbeih, F | 1 |
| Christov, F | 1 |
| Gluth, MB | 1 |
1 other study available for triamterene and Abdominal Migraine
| Article | Year |
|---|---|
Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine.
Topics: Audiometry, Pure-Tone; Auditory Threshold; Betahistine; Dexamethasone; Drug Combinations; Female; Fo | 2018 |